Found a new specimen -
Jenburkt Pharma (
www.jenburkt.com)
This stock is a FMCGish growth type pharma stock, because 90% of its revenues come from India. They do R&D, manufacture and market a whole lot of drugs through medical shops, hospitals and doctors.
Market Cap: Rs. 14 crores
Dividend Yield: 4.24%
P/E: 8.3
RoE: 19%
FY09 Sales & Profits: Rs. 42 crores and Rs. 1.62 crores
4 Yr Sales Growth: 13.3% CAGR
4 Yr Profit Growth: 27% CAGR
Dividend/share from FY05 to FY09: Rs. 1.00, 1.25, 1.25, 1.25, 1.80
Stock price appreciation since 2001: 18% CAGR
However -
- Topline growth is somewhat sluggish
- Margins are quite poor. But they are increasing the margins every year.